Literature DB >> 2105679

Vascular permeability and coagulation during Rickettsia rickettsii infection in dogs.

M G Davidson1, E B Breitschwerdt, D H Walker, M G Levy, C S Carlson, E M Hardie, C A Grindem, M P Nasisse.   

Abstract

The vascular permeability of the ocular fundus, alterations in the coagulation system, and plasma concentrations of thromboxane B2 (TXB2) and 6-keto-prostaglandin F1 alpha (6-keto-PGF1 alpha) were studied in dogs following intradermal inoculation with 5 x 10(5) TCID50 of Rickettsia rickettsii. Twenty-four to 48 hours after the onset of fever and rickettsemia, multifocal areas of retinal vasculitis were evident, which corresponded to areas of altered vascular permeability demonstrated by fluorescein angiography. The number and intensity of retinal vessels with sodium fluorescein leakage peaked during the second week after inoculation, and retinal vascular permeability remained altered during the third week of infection, well past the phase of clinical and clinicopathologic recovery. Development of retinal vasculitic foci was associated with thrombocytopenia, increased concentrations of circulating fibrinogen, and slight prolongation of activated partial thromboplastin time. Increased concentrations of fibrin/fibrinogen degradation products were detected in 4 of 9 dogs. Despite the degree of vascular endothelial damage evident on fluorescein angiographic and histologic studies in these dogs, plasma TXB2 and 6-keto-PGF1 alpha concentrations were not increased.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105679

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  6 in total

1.  The Rickettsia conorii autotransporter protein Sca1 promotes adherence to nonphagocytic mammalian cells.

Authors:  Sean P Riley; Kenneth C Goh; Timothy M Hermanas; Marissa M Cardwell; Yvonne G Y Chan; Juan J Martinez
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

2.  Efficacy of chloramphenicol, enrofloxacin, and tetracycline for treatment of experimental Rocky Mountain spotted fever in dogs.

Authors:  E B Breitschwerdt; M G Davidson; D P Aucoin; M G Levy; N S Szabados; B C Hegarty; A L Kuehne; R L James
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

3.  Contribution of NK cells to the innate phase of host protection against an intracellular bacterium targeting systemic endothelium.

Authors:  Rong Fang; Nahed Ismail; David H Walker
Journal:  Am J Pathol       Date:  2012-05-19       Impact factor: 4.307

4.  Case report: Co-infection of Rickettsia rickettsii and Streptococcus pyogenes: is fatal Rocky Mountain spotted fever underdiagnosed?

Authors:  Gregory A Raczniak; Cecilia Kato; Ida H Chung; Amy Austin; Jennifer H McQuiston; Erica Weis; Craig Levy; Maria da Gloria S Carvalho; Audrey Mitchell; Adam Bjork; Joanna J Regan
Journal:  Am J Trop Med Hyg       Date:  2014-10-20       Impact factor: 2.345

5.  Prednisolone at anti-inflammatory or immunosuppressive dosages in conjunction with doxycycline does not potentiate the severity of Rickettsia rickettsii infection in dogs.

Authors:  E B Breitschwerdt; M G Davidson; B C Hegarty; M G Papich; C B Grindem
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

6.  Efficacy of doxycycline, azithromycin, or trovafloxacin for treatment of experimental Rocky Mountain spotted fever in dogs.

Authors:  E B Breitschwerdt; M G Papich; B C Hegarty; B Gilger; S I Hancock; M G Davidson
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.